CELEX: 62017TA0261
Language: en
Date: 2018-10-24 00:00:00
Title: Case T-261/17: Judgment of the General Court of 24 October 2018 — Bayer v EUIPO — UNI-Pharma (SALOSPIR) (EU trade mark — Opposition proceedings — Application for EU figurative mark SALOSPIR — Earlier EU figurative marks representing coloured stripes and earlier national marks Aspirin — Relative grounds for refusal — Similarity of the signs — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001) — Reputation — Article 8(5) of Regulation No 207/2009 (now Article 8(5) of Regulation 2017/1001) — Use of a sign of more than mere local significance in the course of trade — Article 8(4) of Regulation No 207/2009 (now Article 8(4) of Regulation 2017/1001))

10.12.2018   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 445/17
            
         
      Judgment of the General Court of 24 October 2018 — Bayer v EUIPO — UNI-Pharma (SALOSPIR)
      (Case T-261/17) (1)
      
      ((EU trade mark - Opposition proceedings - Application for EU figurative mark SALOSPIR - Earlier EU figurative marks representing coloured stripes and earlier national marks Aspirin - Relative grounds for refusal - Similarity of the signs - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001) - Reputation - Article 8(5) of Regulation No 207/2009 (now Article 8(5) of Regulation 2017/1001) - Use of a sign of more than mere local significance in the course of trade - Article 8(4) of Regulation No 207/2009 (now Article 8(4) of Regulation 2017/1001)))
      (2018/C 445/22)
      Language of the case: English
      
         Parties
      
      
         Applicant: Bayer AG (Leverkusen, Germany) (represented by: V. von Bomhard and J. Fuhrmann, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented by: A. Folliard-Monguiral, S. Pétrequin and D. Walicka, acting as Agents)
      
         Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Uni-Pharma Kleon Tsetis, Farmakeutika Ergastiria AVEE (Kifisia, Greece) (represented by: C. Chrysanthis, P.-V. Chardalia and A. Vasilogamvrou, lawyers)
      
         Re:
      
      Action brought against the decision of the Fourth Board of Appeal of EUIPO of 17 February 2017 (Case R 2444/2017-4), relating to opposition proceedings between Bayer and Uni-Pharma Kleon Tsetis, Farmakeutika Ergastiria.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Bayer AG to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO) and by Uni-Pharma Kleon Tsetis, Farmakeutika Ergastiria AVEE in the proceedings before the General Court.
               
            
         (1)  OJ C 221, 10.7.2017.